Albuked Market 2026 unlocking new plasma therapy opportunities

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Albuked Market During The Forecast Period 2026–2030?

Historically, expansion was driven by albumin’s clinical application in shock management, reliance on plasma-derived albumin, an increasing incidence of liver disorders, the growth of hospital-based critical care, and its established efficacy in fluid management.

The anticipated growth during the forecast period can be attributed to the rising demand for safer non-plasma products, an increase in burn and trauma cases, the expansion of recombinant protein manufacturing, a surge in ICU admissions, and supportive regulatory frameworks for synthetic proteins.

Key trends observed over the forecast period encompass the increasing adoption of recombinant albumin, a shift away from plasma-derived albumin, greater utilization in critical care settings, a growing preference for synthetic therapeutics, and the expansion of intravenous protein therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19868&type=smp

Which Major Factors Are Driving The Expansion Of The Albuked Market?

The increasing occurrence of liver disorders is anticipated to fuel the expansion of the Albuked market. These disorders encompass a spectrum of conditions that impact liver function, including hepatitis, cirrhosis, fatty liver disease, and autoimmune diseases. The rise in liver disorders stems from factors such as excessive alcohol consumption, obesity, viral infections, exposure to toxins, and genetic predispositions, all of which compromise liver health. Albuked finds application in treating liver disorders, particularly in managing acute liver failure. It functions by maintaining the colloid osmotic pressure of plasma and by binding excess bilirubin in patients experiencing rapid loss of liver function, potentially averting complications like coma. For instance, the American Liver Foundation, a US-based non-profit organization, reported in September 2023 that over 100 million people in the U.S. are impacted by some form of liver disease. Of these, 4.5 million adults (1.8%) have received a formal diagnosis, and an estimated 80-100 million adults in the U.S. suffer from fatty liver disease, often without being aware of their condition. Additionally, the Journal of Hepatology, a Switzerland-based peer-reviewed monthly journal, stated in August 2023 that liver disease accounts for over 2 million deaths each year globally, representing about 4% of all deaths worldwide. This signifies that 1 in every 25 deaths is linked to liver issues, with one-third of these fatalities occurring in women. Among various liver diseases, liver cancer alone is responsible for between 600,000 and 900,000 deaths annually. Consequently, the growing incidence of liver disorders is a key driver for the Albuked market.

What Market Segments Are Evaluated Within The Albuked Market?

The albuked market covered in this report is segmented –

1) By Formulation: Albuked 5%, Albuked 25%, Plasbumin-5, Plasbumin-25

2) By Indication: Hypovolemic Shock, Hypoproteinemia, Acute Respiratory Distress Syndrome (ARDS), Cardiopulmonary Bypass, Acute Liver Failure

3) By Packaging Size: 50 mL, 250 mL, 500 mL

4) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies

5) By End User: Adult Patients, Geriatric Patients

What Industry Trends Are Redefining The Albuked Market?

A significant trend in the Albuked market is the focus on developing advanced products, such as human albumin injection therapy, to provide treatment options for critical medical conditions. This therapy involves the use of human serum albumin (HSA), a protein sourced from human plasma, for various medical treatments. It is primarily applied in clinical settings to manage ailments like hypoalbuminemia, liver cirrhosis, trauma, burns, and for fluid resuscitation during surgical procedures. For instance, in July 2023, Grifols S.A., a Spain-based manufacturer of plasma-derived medicines, announced the phase 3 completion of PRECIOSA, a study designed to determine the potential of long-term albumin-based treatment with Grifols S.A.’s Albutein. The clinical study aims to increase the survival time of patients suffering from decompensated cirrhosis and ascites until a suitable transplant is available.

Who Are The Top Market Participants Influencing The Albuked Market?

Major companies operating in the albuked market are Kedrion Biopharma Inc.

Read the full albuked market report here:

https://www.thebusinessresearchcompany.com/report/albuked-global-market-report

Which Region Currently Holds The Largest Share Of The Albuked Market?

North America was the largest region in the albuked market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albuked market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Albuked Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19868&type=smp

Browse Through More Reports Similar to the Global Albuked Market 2026, By The Business Research Company

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Automated Algo Trading Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-algo-trading-global-market-report

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795